A Randomized, Open-label, Single Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin After Oral Administration in Healthy Volunteers

Trial Profile

A Randomized, Open-label, Single Dose, Two-treatment, Two-period, Two-sequence Crossover Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin After Oral Administration in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Atorvastatin (Primary) ; Amlodipine; Telmisartan
  • Indications Essential hypertension; Hyperlipidaemia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Aug 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000810)
    • 01 Jul 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 07 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top